Progressing From Metformin to Sulfonylureas or Meglitinides

The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.

Source: Workplace Health and Safety - September 11, 2016 Category: Occupational Health Authors: Grant, J. S., Graven, L. J. Tags: Continuing Education Source Type: research